Part 1 of an interview with Access Pharmaceuticals' C.E.O. Jeffrey B. Davis who offers insight on the Access Pharmaceuticals corporate overview, and the launch of revolutionary Chemotherapy treatment product MuGard.

http://www.accesspharma.com/newsroom/q-a-with-access-pharmaceuticals-ceo-jeffrey-b-davis-pt-1-corporate-overview-and-mugard/